How is the Milestone Pharmaceuticals Inc today?

The Milestone Pharmaceuticals Inc today is trading in the down by -2.31% at 1.69.

How has Milestone Pharmaceuticals Inc performed historically?

The Milestone Pharmaceuticals Inc is currently trading down -2.31% on an intraday basis in the past week the index rose 9.74%. The index has been up 3.68% in the past quarter and rose 12.67% in the past year. You can view this in the overview section.

What is Milestone Pharmaceuticals Inc Annual Net Profit?

Milestone Pharmaceuticals Inc Annual Net Profit rose 30.44% in the last year to $41.52 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Milestone Pharmaceuticals Inc Price to Earning Ratio?

Milestone Pharmaceuticals Inc Price to Earning Ratio is -1.74, which is negative.

What is Milestone Pharmaceuticals Inc Stock Price?

Milestone Pharmaceuticals Inc Stock Price rose 12.67% and underperformed its sector by 13.87% in the past year.

What is Milestone Pharmaceuticals Inc Quarterly Net profit?

Milestone Pharmaceuticals Inc Quarterly Net profit fell 100.51% YoY to $20.76 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Milestone Pharmaceuticals Inc Debt to Equity Ratio?

Milestone Pharmaceuticals Inc Debt to Equity Ratio of 4.17 is higher than 1. This implies that company assets are financed through debt.

What is Milestone Pharmaceuticals Inc Return on Equity(ROE)?

Milestone Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -277.55%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Milestone Pharmaceuticals Inc Mutual Fund Holding?

Milestone Pharmaceuticals Inc Mutual Fund Holding increased by 0.91% in the last quarter to 3.12.

What is Milestone Pharmaceuticals Inc Promoter Share Holding?

Milestone Pharmaceuticals Inc Promoter Share Holding stayed the same in the most recent quarter at 1.75%.

What is Milestone Pharmaceuticals Inc Interest Coverage Ratio?

Milestone Pharmaceuticals Inc Interest Coverage Ratio is -10.59, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Milestone Pharmaceuticals Inc Institutional Holding?

Milestone Pharmaceuticals Inc Institutional Holding decreased by 18.57% in the last quarter to 27.92.

Milestone Pharmaceuticals Inc XNAS: MIST

Milestone Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Milestone Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Milestone Pharmaceuticals Inc
Rating: 1.45050
Author: Trendlyne DVM scores

about

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

1.69 -0.04 (-2.31%)

32.94% Fall from 52W High

732.5K XNAS Volume

XNAS 03 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Milestone Pharmaceuticals Inc is on 05 Jun 2025 for the purpose of Jefferies Global Healthcare Conference See details

Not Eligible

Expensive Valuation

3.0 / 100

Technically Neutral

55.0 / 100

1Yr Price target upside is 507%

4 analysts

Milestone Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Milestone Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be admi...

32.94% Fall from 52W High

SWOT Analysis

Milestone Pharmaceuticals Inc Live Price Chart

Milestone Pharmaceuticals Inc FAQ

How is Milestone Pharmaceuticals Inc today?

Milestone Pharmaceuticals Inc today is trading in the red, and is down by -2.31% at 1.69.

How has Milestone Pharmaceuticals Inc performed historically?

Milestone Pharmaceuticals Inc is currently trading down -2.31% on an intraday basis. In the past week the stock rose 9.74%. stock has been up 3.68% in the past quarter and rose 12.67% in the past year. You can view this in the overview section.